secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001104659-23-121675
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel receives Nasdaq notice for late Q3 10-Q filing; 60 days to submit compliance plan
--------------------------------------------------------------------------------

- Notice received Nov 21, 2023 for failure to timely file Quarterly Report for period ended Sep 30, 2023.
- Company has 60 calendar days (to Jan 20, 2024) to submit a plan to regain compliance.
- If accepted, Nasdaq may grant up to 180 days (to May 20, 2024) to file the overdue report.
- No immediate effect on listing, but no assurance compliance can be regained.
- Common stock (CYCC) and preferred stock (CYCCP) listed on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923121675/0001104659-23-121675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923121675/tm2331442d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-121675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer